The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Jan 2011 15:30

RNS Number : 1394A
Ipso Ventures PLC
26 January 2011
 



IPSO Ventures plc

HOLDING(S) IN COMPANY

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

IPSO Ventures plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights:

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments:

An event changing the breakdown of voting rights:

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

RAB Capital plc acting as discretionary manager for RAB Special Situations (Master) Fund Ltd

4. Full name of shareholder(s) (if different from 3.):iv

Credit Suisse Client Nominee (UK) Limited

5. Date of the transaction and date on which the threshold is crossed or reached: v

20.01.2011

6. Date on which issuer notified:

26.01.2011

7. Threshold(s) that is/are crossed or reached: vi, vii

33-32%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY SHARES*

GB00B1GDWB47

5,588,233

5,588,233

n/a

5,178,233

31.50%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise / Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

5,178,233

31.50%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

*RAB Capital plc acts as investment manager for RAB Special Situations (Master) Fund Limited who are the beneficial owners of the securities. The legal title to these securities is held on behalf of the beneficial owners by their nominee, Credit Suisse Client Nominees (UK) Limited.

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

13. Additional information:

n/a

14. Contact name:

RAB Capital plc - Legal Team

15. Contact telephone number:

020 7389 7000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUGPGUPGGAQ
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.